Patent · US Active

Compounds for targeting endothelial cells, compositions containing the same and methods for their use

US7884183B2 · kind B2 · utility

7Cited by

15References

14Claims

0Family size

Assignee

Bracco Suisse SA · CH

Inventors

Mathew A. Von Wronski · Moorestown, US
Edmund R. Marinelli · Tucson, US
Adrian D. Nunn · Lambertville, US
Radhakrishna K. Pillai · Kendall Park, US
Kondareddiar Ramalingam
Michael F. Tweedle · Princeton, US
Karen E. Linder · Kingston, US
Palaniappa Nanjappan · Princeton, US
Natarajan Raju · Kendall Park, US
Feng Yan · Carouge, CH
Michel Schneider · Troinex, CH

Key dates

Filing date	May 5, 2006
Grant date	Feb 8, 2011
Priority date	—
Expiry date	Nov 14, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds for targeting endothelial cells, tumor cells or other cells that express the NP-1 receptor, compositions containing the same and methods for their use. Additionally, the present invention includes diagnostic, therapeutic and radiotherapeutic compositions useful for visualization, therapy or radiotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.